Plan to resume MAGNITUDE-2 patient enrollment and dosing FDA engagement ongoing regarding clinical hold on MAGNITUDE Phase 3 ...

Concept Medical Inc. is proud to announce the successful enrollment of the first patients in the STARS DAPT randomized ...

Onvansertib added to FOLFIRI/bev first-line standard of care regimen showed dose-dependent improvement in overall response rates and durability trends as measured by progression-free survival in patie ...

A new randomized clinical trial has revealed that just 24 minutes of listening to specially designed music paired with ...

Alphamab Oncology (Stock Code: 9966.HK) announced that the results from a phase III clinical study for the treatment of ...

A trial found six weeks of yoga improved sleep quality and reduced fatigue in people with MS, suggesting its use as a ...

Tirzepatide users on hormone therapy had added improvements in weight, cardiometabolic mar ...

The FDA cleared an investigational new drug application to advance NOV05 in a phase 2 clinical trial in noninfectious ...

Specialty CNS Research Center Strengthens Trial Execution and Patient Diversity in Alzheimer's Agitation Study - POTOMAC, MD / ACCESS Newswire / January 22, 2026 /IGC Pharma, Inc. (NYSE American:IGC) ...

Participants in the combined treatment group lost significantly more weight at 3, 6, and 12 months and were more likely to lose 5%, 10%, or >15% of their body weight at 12 months compared with DELI al ...

A voice-activated device reduces mental distress while improving quality of life, diabetes self-care, and glycemic control.

An interactive smart speaker intervention reduced mental distress and improved diabetes-related outcomes in older adults with type 2 diabetes. Participants using the virtual assistant showed ...